Holen Sie sich die Stockscreener-App
1.06
2.91%
0.03
Handel nachbörslich:
1.05
-0.01
-0.94%
Schlusskurs vom Vortag:
$1.03
Offen:
$1.06
24-Stunden-Volumen:
86,304
Relative Volume:
0.90
Marktkapitalisierung:
$36.49M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-12.02
EPS:
-0.0882
Netto-Cashflow:
-
1W Leistung:
+4.95%
1M Leistung:
-6.19%
6M Leistung:
-34.16%
1J Leistung:
-87.75%
1-Tages-Spanne:
$1.03
$1.08
1-Wochen-Bereich:
$0.9801
$1.09
52-Wochen-Spanne:
$0.51
$9.35
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
Firmenname
Jupiter Neurosciences Inc
Sektor
Branche
Telefon
(561) 406-6154
Adresse
1001 NORTH US HWY 1, JUPITER
Vergleichen Sie JUNS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
1.06 | 35.46M | 0 | 0 | 0 | -0.0882 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Jupiter Neurosciences Inc Aktie (JUNS) Neueste Nachrichten
Why Jupiter Neurosciences Inc. stock remains on buy listsMarket Rally & Reliable Price Breakout Signals - ulpravda.ru
Why Jupiter Neurosciences Inc. stock is trending among retail tradersNew Guidance & Free AI Powered Buy and Sell Recommendations - ulpravda.ru
Will Jupiter Neurosciences Inc. stock benefit from AI adoptionEarnings Recap Summary & Free Verified High Yield Trade Plans - ulpravda.ru
How institutional buying supports Jupiter Neurosciences Inc. stockWeekly Trend Recap & Daily Volume Surge Signals - ulpravda.ru
Will Jupiter Neurosciences Inc. stock gain from lower inflationJuly 2025 Highlights & Free Reliable Trade Execution Plans - ulpravda.ru
Can Jupiter Neurosciences Inc. stock deliver strong Q4 earnings2025 Trading Volume Trends & Verified Stock Trade Ideas - ulpravda.ru
Aug Volume: Why Jupiter Neurosciences Inc stock is trending among retail tradersWeekly Trading Summary & Weekly Momentum Picks - moha.gov.vn
Will Jupiter Neurosciences Inc. stock split again soonGlobal Trade Effects & High Return Wealth Building - ulpravda.ru
Jupiter Neurosciences expands equity financing through SEPA advances - MSN
What margin trends mean for Jupiter Neurosciences Inc. stockInflation Impact on Stocks & Small Investment Big Gains - bollywoodhelpline.com
Jupiter Neurosciences Expands Equity Financing Through SEPA Advances - TipRanks
Jupiter Neurosciences Signs Multiple Material Agreements - TradingView — Track All Markets
Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6 - marketscreener.com
The best and worst-performing stocks of 2025 | 2025-12-22 | Investing News - Stockhouse
Jupiter Neurosciences Shareholders Approve Key Governance Measures - TipRanks
The best and worst-performing stocks of 2025 - MSN
New Highs: What margin trends mean for Jupiter Neurosciences Inc. stockJuly 2025 Gainers & Community Verified Trade Signals - moha.gov.vn
Stock Analysis: What margin trends mean for Jupiter Neurosciences Inc. stockMarket Sentiment Review & AI Enhanced Market Trend Forecasts - Улправда
Will Jupiter Neurosciences Inc. stock sustain high P E ratiosEarnings Performance Report & Technical Pattern Based Signals - Улправда
Can Jupiter Neurosciences Inc. stock maintain growth trajectoryMarket Sentiment Review & Low Risk High Win Rate Picks - Улправда
Fed Meeting: Can Jupiter Neurosciences Inc. stock maintain growth trajectoryJuly 2025 Rallies & Reliable Entry Point Trade Alerts - Улправда
Jupiter Neurosciences Achieves Regulatory and Commercial Milestones in First Year as Public Company - citybuzz -
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon | Corporate - EQS News
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon - NewMediaWire
About Us - FinancialContent
$50B+ Longevity Opportunity: Jupiter Neurosciences CEO Christer Rosen & President Alison Silva, Live at Nasdaq - Yahoo Finance
Jupiter Neurosciences Marks Transformational First Year as - GlobeNewswire
Why Jupiter Neurosciences Inc. stock attracts global investorsWeekly Profit Summary & Daily Chart Pattern Signals - Newser
Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum - Yahoo Finance
Jupiter Neurosciences (NASDAQ: JUNS) to Join NobleCon21 Emerging Growth Equity Conference - Stock Titan
Published on: 2025-11-27 23:20:01 - moha.gov.vn
Jupiter Neurosciences files rospectus related to resale of up to 10 million shares of our common stock by selling stockholder - marketscreener.com
Jupiter Neurosciences Inc Stock Analysis and ForecastPortfolio Diversification Tips & Watch Expert Picks Before They Rally - earlytimes.in
How Jupiter Neurosciences Inc. stock reacts to global recession fearsTrade Analysis Report & Expert Verified Stock Movement Alerts - newser.com
Will Jupiter Neurosciences Inc. stock deliver shareholder valueJuly 2025 Market Mood & Low Risk Investment Opportunities - newser.com
How Jupiter Neurosciences Inc. stock benefits from strong dollar2025 Pullback Review & Pattern Based Trade Signal System - newser.com
Is Jupiter Neurosciences Inc. stock overvalued by current metricsIndex Update & Weekly Breakout Stock Alerts - newser.com
A activity2025 Key Highlights & High Accuracy Buy Signal Tips - newser.com
Why hedge funds are buying Jupiter Neurosciences Inc. stockGlobal Markets & Free Reliable Trade Execution Plans - newser.com
Is Jupiter Neurosciences Inc. stock safe for conservative investorsProfit Target & Consistent Return Investment Signals - newser.com
Will Jupiter Neurosciences Inc. stock continue dividend increasesJuly 2025 Sector Moves & Risk Managed Trade Strategies - newser.com
Finanzdaten der Jupiter Neurosciences Inc-Aktie (JUNS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Jupiter Neurosciences Inc-Aktie (JUNS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Silva Alison D. | Pres + Chief Business Officer |
Jul 01 '25 |
Buy |
1.03 |
750 |
772 |
112,777 |
| ROSEN CHRISTER | CEO and Chairman |
Jul 01 '25 |
Buy |
1.02 |
3,600 |
3,667 |
11,078,892 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 02 '25 |
Option Exercise |
0.00 |
110,227 |
0 |
110,227 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 30 '25 |
Buy |
1.03 |
950 |
978 |
112,027 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 27 '25 |
Buy |
1.03 |
850 |
877 |
111,077 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 02 '25 |
Option Exercise |
0.00 |
973,466 |
0 |
11,067,476 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 30 '25 |
Buy |
1.02 |
7,650 |
7,810 |
11,075,292 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 27 '25 |
Buy |
1.06 |
166 |
176 |
11,067,642 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):